Time: 8:30am-5:00pm

Location: MaRS Auditorium, 101 College Street, Toronto Ontario

Register at : https://www.eventbrite.ca/e/the-future-of-health-innovation-tickets-42907311925?aff=ehomecard

The Future of Health Innovation conference presented by the University of Toronto will highlight and showcase health and life sciences innovation from the University Toronto and the Toronto community including those from our affiliated hospital partners. 

The day will consist of:

Theme 1:

Health Technologies – Wearables and Robotics

This segment will showcase new and exciting wearable, assistive devices and robotic technologies from the Toronto ecosystem. Engaging groups such as Toronto Rehab Institute, Institute for Biomaterials and Biomedical Engineering and the Faculty of Applied Sciences and Engineering to discuss the future of health tech and the areas in which we are translating research here in Toronto and in partnership with our local Toronto companies.

Theme 2:

Advancement of cell-based therapies and tissue-based technologies. 

An introduction of the advancement of microfluidics at UofT and organ-on-a chip related technologies.  Highlighting UofT partnerships and top researchers in this field.  This will be followed by a panel discussion on the commercialization of cell therapy and tissue-based technologies and treatments with industry experts, venture capital and pharmaceutical companies in this field.

Technology/Start-up Showcase

The technology and start-up showcase will highlight the most innovative health and life sciences companies coming out of the Toronto ecosystem.

Schedule

  • 8:15am-8:45am : Registration and light breakfast

  • 8:45am-9:00am : Opening Remarks

    Vivek Goel
    Vice-President Research and
    Innovation
    University of Toronto

  • 9:00am-9:25am : Keynote Speaker: The role of AI in Healthcare Transformation

    Nathalie Le Prohon
    Healthcare Industry Lead
    IBM Canada

  • 9:30am-10:45am : Panel Session:

    Health Tech and Robotics? What are the impacts to the Future of Healthcare and the Medtech ecosystem

    Moderator: Zayna Khayat
    Future Strategist
    Saint Elizabeth Health Care

    Goldie Nejat
    Associate Professor
    University of Toronto

    Dina Nikitina
    Chief Operating Officer
    Trexo Robotics
    (UofT Start-up company)

    William Charnetski
    Ontario’s Chief
    Health Innovation Strategist

    Jolene McNeil
    Modality Manager,
    Patient Care and
    Monitoring Solutions
    Philips Healthcare

  • 10:45am-11:00am : Break

  • 11:00am-11:50am : Innovation Demonstrations

    in partnership with

  • 11:50am-12:15pm : Speaker

    Tony Chahine

    CEO, Myant Technologies

  • 12:15am-1:00pm : Lunch

  • 1:00pm-1:15pm : Introduction to Lab-On-A-Chip Innovation


    Roman Szumski
    Vice-President Life Sciences
    National Research Council Canada

  • 1:15pm-1:30pm : Highlighting lab-on-a chip research and innovation.


    Milica Radisic
    Professor
    University of Toronto

  • 1:30pm-2:45pm : Panel Session:

    Commercialization of tissue-based technologies and cell-based therapies

    Moderator: Michael May
    CEO, CCRM

    Stefan Larson
    CEO Northern Biologics
    Versant Ventures

    Jean-Francis Houle
    Director, Medical Devices
    National Research Council

    Molly Shoichet
    Ontario Chief Scientist
    Professor
    University of Toronto

    Shreya Shukla
    Scientist/Entrepreneur
    ProT Therapeutics

  • 2:45pm-3:00pm : Break

  • 3:00pm – 3:30pm : The promise of a healthy heart

    A 30-minute dive into the cutting edge innovation from Toronto’s Ted Rogers Centre for Heart Research
  • 3:30pm-4:00pm : UofT Life Sciences Start-ups and Entrepreneurs

    Soror Sharifpoor
    Co-founder and Chief Executive Officer (CEO)

    Mark Cicero, MD, BESc, FRCPC
    Chief Operating Officer
    Co-founder

  • 4:00pm-4:40pm : RBC Innovation & Entrepreneurship Speaker Series with Dr. Catherine Zahn on Innovation: Not Just Things

    Dr. Catherine Zahn, C.M.
    President and Chief Executive Officer
    Centre for Addiction and Mental Health (CAMH)

  • 4:40pm – 5:00pm : Closing Remarks

Technology and Start-up Showcase

The technology and start-up showcase will highlight the most innovative health and life sciences companies coming out of the Toronto ecosystem.

  • AGE-WELL NCE (Aging Gracefully across Environments using Technology to Support Wellness, Engagement and Long Life NCE Inc.) is Canada’s technology and aging network. AGE-WELL is dedicated to the creation of technologies and services that benefit older adults and caregivers. Our aim is to help older Canadians maintain their independence, health and quality of life through technologies and services that increase their safety and security, support their independent living, and enhance their social participation.

  • Braze Mobility Inc., creating innovative and inclusive solutions that increase independent and safe mobility. The company recently launched low-cost, after-market systems that transform any wheelchair into a “smart” wheelchair by automatically detecting obstacles and providing feedback to the driver. The company’s products improve spatial awareness and rear visibility when operating a wheelchair. Located at the Impact Centre at the University of Toronto, the team is made up of a diverse, trans-disciplinary team with a passion to create a more accessible world.

  • Ontario Centres of Excellence (OCE) drives the development of Ontario’s economy by helping create new jobs, products, services, technologies and businesses.

    In partnership with industry, OCE co-invests to commercialize innovation originating in the province’s publicly funded colleges, universities and research hospitals

    Advanced health technologies is an important area of focus for OCE, with 30% of OCE’s investments this year going to industry-academic collaborative research and commercialization at Ontario’s universities, colleges and research hospitals for work in this area. Since 2004 OCE has invested over $22M into advanced health projects, with an additional $31.5M of cash and in-kind support from industry partners.

  • SensOR Medical provides a virtual sense of touch in minimally invasive surgery to improve surgical precision and reduce medical error. This virtual sense of touch is provided by ForceFilm: a patent-pending force-sensing film that can be added-on to any make or model of minimally invasive surgical instrument.

    SensOR’s vision is to more effectively and efficiently train surgical residents, increase safety of MIS, and use our force-sensing technology to enable new surgical procedures that are not possible today.

  • Steadiwear Inc. caters to the dexterity needs of those suffering from hand tremors by pioneering novel stabilization solutions. Steadiwear Glove has developed a glove that responsively stabilizes the wrist joint in Essential Tremor and Parkinson’s disease patients using revolutionary battery-free vibration damping technology. This will allow individuals with tremors to go about their daily activities with significantly less frustration, thereby enjoying more independence & an improved quality of life.

  • Trexo Robotics is building one of the first wearable robotic devices designed to help children with disabilities experience walking. Comprised of two wearable leg attachments, Trexo Plus can transform any passive walker into a fully powered robotic device that is affordable, fully mobile and safe for independent use. Currently, Trexo’s first product, Trexo Plus, is set for a clinical pilot trial with one of the largest pediatric rehabilitation hospitals in the USA. Founded in 2016 by two University of Waterloo engineering graduates, Trexo is on a mission to redefine enabling technologies for people of all ages and abilities.

  • ImmunoBiochem is improving patient outcomes through innovation in targeted therapy. ImmunoBiochem is solving the problem of tumor heterogeneity in solid tumors to address significant unmet need in indications, where no other biological therapies are available to patients, such as triple-negative breast cancer. Via a novel approach, ImmunoBiochem has developed highly selective lead molecules that can efficiently eradicate cancer cells while sparing normal, healthy cells. This is achieved by targeting unique proteins in the secretomes of cancer cells (accumulating and constantly recycled in the tumor microenvironment) with Antibody Drug Conjugates (ADCs) – a promising class of anticancer therapeutics that combine the selectivity of targeted biologics with the potency of highly cytotoxic small-molecule drugs. The IMB-212 lead is in preclinical development for triple-negative breast cancer and other challenging solid tumor indications.

  • The Centre for Aging + Brain Health Innovation (CABHI) is a solution accelerator for the aging and brain health sector, providing funding and support to innovators for the development, testing, and dissemination of new ideas and technologies that address unmet brain health and seniors’ care needs. Established in 2015, it is the result of the largest investment in brain health and aging in Canadian history. CABHI is a unique collaboration of health care, science, industry, not-for-profit and government partners whose aim is to help improve quality of life for the world’s aging population, allowing older adults to age safely in the setting of their choice while maintaining their cognitive, emotional, and physical well-being. For more information, please visit: www.cabhi.com.

  • Regular restful sleep is critical for improved memory, mood and overall health. Yet over 45% of the adult population wakes up feeling tired on most mornings. Somnitude aims to harness circadian science to improve sleep and health. Our first products included a series of blue light filtering glasses which prevent light induced sleep disruption. The second product is a mobile application which helps people travel without jet lag.https://blueblockglasses.com/

  • MyndTec Inc., a Canadian medical technology company, develops and distributes innovative therapies, such as MyndMove, based upon advanced application of functional electrical stimulation (FES), to improve voluntary upper limb motor function and independence to individuals paralyzed by stroke and spinal cord injury. MyndMove is approved for clinical use in Canada and the United States. More information can be found at www.myndtec.com

  • Winterlight is developing a cognitive assessment for early detection and better characterization of Alzheimer’s disease. We collect natural speech through our iPad assessment app, analyze the acoustic and lexical properties and extract a wide range of speech and language variables. These variables are then fed into machine learning classifiers which we use to predict whether an individual has Alzheimer’s or not.

  • Polumiros Inc. is a biomaterials start-up company founded based on innovative research at the University of Toronto and the University Health network, specializing in the development of novel immunomodulatory polymer technology. The company’s primary focus is on the development of biocompatible polymeric biomaterials, in the form of medical device coatings, tissue regeneration scaffolds and drug carriers, that reduce biomedical implant-associated inflammation and fibrosis while enhancing bio-integration. Polumiros Inc.’s family of polymers is amenable to being used as a platform technology as its immunomodulatory character can be maintained while producing biomaterials with a wide range of physical properties suitable for diverse applications.

  • Neurescence has developed and commercialized a miniature microscope initially targeted to the Neurology research market. Our Quartet™ system gets implanted in multiple regions of the brain and spine and follows the activities of 100s of neurons in each region for months while the subject freely moves around. Our hardware-software suite is the only technology that allows establishing a causal connection between the effect of the treatment, such as a drug, on both the neuronal micro-circuitry and the disease phenotype. This extremely powerful approach takes the process of discovering and developing treatments from a trial and error method to an intelligent design.

  • Centivizer is a University of Toronto spinoff company that develops products that stimulate people with dementia, physically, cognitively, and socially. The Centivizer system includes modules that provide self initiated rewarding activities. Centivizer products are designed to be used at any time without the need for facilitation.

  • EBT Medical develops clinical-grade, discrete, non-invasive neurostimulation therapies for the enormous and growing untreated /under-treated Pelvic Floor Disorder market starting with Overactive Bladder. Our first product is a non-Rx wearable neurostimulator and associated eco-system which, when used for just 30 minutes 2x per week, delivers prescription strength efficacy without any side effects.

    For the first time, Overactive Bladder sufferers can receive clinical-grade treatment for their very private bladder issues in a discrete, direct-to-consumer manner.

Presented By:

 

In Partnership with:

 

Back to Top ↑

© 2018 Office of the Vice-President, Research and Innovation. All rights reserved. | Site map | Accessibility | Log in